We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
VRDN icon
76
Viridian Therapeutics
VRDN
$2.59B
$2.59B $22.82 0.83%
NAMS icon
77
NewAmsterdam Pharma
NAMS
$2.58B
$2.58B $21.58 0.42%
BEAM icon
78
Beam Therapeutics
BEAM
$2.54B
$2.54B $24.56 1.13%
ZLAB icon
79
Zai Lab
ZLAB
$2.47B
$2.47B $22.04 8.93%
RCUS icon
80
Arcus Biosciences
RCUS
$2.47B
$2.47B $19.36 1.36%
ADMA icon
81
ADMA Biologics
ADMA
$2.45B
$2.45B $10.95 0.54%
MBX icon
82
MBX Biosciences
MBX
$2.43B
$2.43B $50.46 6.43%
AUPH icon
83
Aurinia Pharmaceuticals
AUPH
$2.31B
$2.31B $17.33 2.54%
SLS icon
84
SELLAS Life Sciences
SLS
$2.29B
$2.29B $11.35 6.51%
PGEN icon
85
Precigen
PGEN
$2.29B
$2.29B $6.39 3.18%
CLDX icon
86
Celldex Therapeutics
CLDX
$2.28B
$2.28B $28.97 1.36%
FTRE icon
87
Fortrea Holdings
FTRE
$2.27B
$2.27B $23.92 0.58%
AGIO icon
88
Agios Pharmaceuticals
AGIO
$2.22B
$2.22B $37.19 0.03%
BHVN icon
89
Biohaven
BHVN
$2.22B
$2.22B $14.69 25%
VCEL icon
90
Vericel Corp
VCEL
$2.2B
$2.2B $42.97 4.96%
IMNM icon
91
Immunome
IMNM
$2.15B
$2.15B $18.26 1.44%
PHVS icon
92
Pharvaris
PHVS
$2.15B
$2.15B $30.68 0.07%
HRMY icon
93
Harmony Biosciences
HRMY
$2.1B
$2.1B $36.03 5.95%
VERA icon
94
Vera Therapeutics
VERA
$2.09B
$2.09B $29.05 6.89%
LKFT icon
95
Lakefront Biotherapeutics American Depositary Shares
LKFT
$2.06B
$2.06B $31.40 2.68%
ZYME icon
96
Zymeworks
ZYME
$2.04B
$2.04B $28.44 1.14%
BRVE
97
Braveheart Bio
BRVE
$1.93B
$1.93B $21.48 2.09%
XNCR icon
98
Xencor
XNCR
$1.92B
$1.92B $25.84 2.7%
SRPT icon
99
Sarepta Therapeutics
SRPT
$1.92B
$1.92B $18.18 2.05%
RXRX icon
100
Recursion Pharmaceuticals
RXRX
$1.92B
$1.92B $3.58 1.65%
2 3
4
5 6

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.26T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $136B, Regeneron Pharmaceuticals (REGN) at $84.3B and Moderna (MRNA) at $80.9B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.